The Lancet Infectious Diseases. Clinical trials versus the real world in tuberculosis control. Lancet Infect Dis 2024; 24: 1287—In this Editorial, the link for further reading on the trial on 4-month therapy of tuberculosis in San Francisco, CA, USA, s...
Since the COVID-19 pandemic, genomic surveillance for the pneumoviruses human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) has increased substantially worldwide (appendix). In a recent article in The Lancet Infectious Diseases, Sl...
A HIV programme designed for adolescent girls and young women in sub-Saharan Africa celebrates its tenth anniversary on World AIDS Day this year. Udani Samarasekera reports.
The Newsdesk piece “Global upsurge in dengue in 2024”1 highlights the alarming rise in dengue cases globally, with Brazil, the world's hardest-hit country, reporting the largest dengue epidemic in recorded history, with more than 6·5 million confirmed ...
Tuberculosis remains a public health concern, and electronic monitors show promise in improving treatment adherence and health outcomes among patients with tuberculosis. This Review aims to provide a comprehensive understanding of the implementation ba...
U=Me is the title of a short film of around 28 minutes that can help in disseminating awareness about various aspects of HIV infection, including misconceptions and stigma. Directed by Umesh Vinayak Kulkarni and produced by Sanjay Pujari, the short fil...
CPA is associated with substantial mortality. Advancing age, CPA subtype, and underlying comorbidities are important predictors of mortality. Future studies should focus on identifying appropriate treatment strategies tailored to different risk groups.
Chronic pulmonary aspergillosis (CPA) is a collection of progressive diseases of the lung caused by infection with members of the Aspergillus genus. The five subtypes of CPA are aspergilloma, Aspergillus nodule(s), chronic cavitary pulmonary aspergillo...
Monkeypox virus (MPXV) causes mpox, a disease largely confined to west and central Africa until 2022, when the global spread of MPXV clade IIb was declared a public health emergency of international concern (PHEIC). Another PHEIC was declared in 2024 f...
In the last twenty years, the WHO public health approach to AIDS has made significant progress around the world. The scale-up of antiretroviral therapy (ART) has meant that ART coverage is currently at 75% and rising to the point where many now believe...
We did a systematic review and meta-analysis of trials of treatment for rifampicin-susceptible tuberculosis to evaluate the representativeness of participants compared with characteristics of the global population of people with tuberculosis, and the a...
In this 14-day trial, quabodepistat plus delamanid plus bedaquiline, a novel three-drug combination, appeared to be safe, well tolerated, and provided robust early bactericidal activity in adults with drug-susceptible pulmonary tuberculosis. Further ev...
For the first time in 60 years, the tuberculosis drug development pipeline promises novel drugs and treatment strategies for safe, well tolerated, highly efficacious, and short treatment for tuberculosis, the leading cause of death from a curable infec...
The re-election of Donald Trump as the 47th president of the USA has raised concerns among health-care professionals and public health experts about the future of global health and pandemic preparedness.1 Trump's COVID-19 response was marked by unclear...
The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such as influenza, COVID-19, respiratory syncytial virus (RSV), and pneumococcal disease contribute significantly to global morbidit...
Brazilian researchers published a Correspondence piece listing some “key lessons” learned after the Zika aftermath in Brazil.1 In the last decade, Brazil has been the epicentre of two health emergencies, Zika and COVID-19, with particular consequences ...